Neutron Therapeutics
Pre-clinicalBoron Neutron Capture Therapy (BNCT) is a type of radiation therapy that has the potential to target malignant tissue at the cellular level. The sparing of healthy tissue could eliminate the need for fractionation, allowing treatment protocols to be carried out in as little as a single session.
Founded
2015
Focus
OncologyRadiotherapy
About
Boron Neutron Capture Therapy (BNCT) is a type of radiation therapy that has the potential to target malignant tissue at the cellular level. The sparing of healthy tissue could eliminate the need for fractionation, allowing treatment protocols to be carried out in as little as a single session.
Funding History
2Total raised: $45M
Series B$30MUndisclosedNov 15, 2022
Series A$15MUndisclosedMar 15, 2020
Company Info
TypePrivate
Founded2015
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile